Research demonstrates a huge problem with all COVID-19 vaccines.
Canadian immunologist and vaccine researcher Byram Bridle, Ph.D., has gained access to Pfizer’s biodistribution study from the Japanese regulatory agency. The research demonstrates a huge problem with all COVID-19 vaccines
The assumption that vaccine developers have been working with is that the mRNA in the vaccines would primarily remain in and around the vaccination site. Pfizer’s data, however, show the mRNA and subsequent spike protein are widely distributed in the body within hours
This is a serious problem, as the spike protein is a toxin shown to cause cardiovascular and neurological damage. It also has reproductive toxicity, and Pfizer’s biodistribution data show it accumulates in women’s ovaries
Once in your blood circulation, the spike protein binds to platelet receptors and the cells that line your blood vessels. When that happens, it can cause platelets to clump together, resulting in blood clots, and/or cause abnormal bleeding
Pfizer documents submitted to the European Medicines Agency also show the company failed to follow industry-standard quality management practices during preclinical toxicology studies and that key studies did not meet good laboratory practice standards
The more we learn about the COVID-19 vaccines, the worse they look. In a recent interview with Alex Pierson (above), Canadian immunologist and vaccine researcher Byram Bridle, Ph.D., dropped a shocking truth bomb that immediately went viral, despite being censored by Google.
It also was featured in a “fact” check by The Poynter Institute’s Politifact, which pronounced Bridle’s findings as “false” after interviewing Dr. Drew Weissman, a UPenn scientist who is credited with helping to create the technology that enables the COVID mRNA vaccines to work. But, as you can see below, unlike Bridle, Politifact neglected to go beyond interviewing someone with such a huge stake in the vaccine’s success.
In 2020, Bridle was awarded a $230,000 government grant for research on COVID vaccine development. As part of that research, he and a team of international scientists requested a Freedom of Information Act (FOIA) access to Pfizer’s biodistribution study from the Japanese regulatory agency. The research, previously unseen, demonstrates a huge problem with all COVID-19 vaccines.
“We made a big mistake,” Bridle says. “We thought the spike protein was a great target antigen; we never knew the spike protein itself was a toxin and was a pathogenic protein. So, by vaccinating people we are inadvertently inoculating them with a toxin.”
Pfizer Omitted Industry-Standard Safety Studies
What’s more, TrialSite News reports that Pfizer documents submitted to the European Medicines Agency [EMA] reveal the company “did not follow industry-standard quality management practices during preclinical toxicology studies … as key studies did not meet good laboratory practice (GLP).”
Neither reproductive toxicity nor genotoxicity (DNA mutation) studies were performed, both of which are considered critical when developing a new drug or vaccine for human use. The problems now surfacing matter greatly, as they significantly alter the risk-benefit analysis underlying the vaccines’ emergency use authorization. As reported by TrialSite News:
“Recently, there has been speculation regarding potential safety signals associated with COVID-19 mRNA vaccines. Many different unusual, prolonged, or delayed reactions have been reported, and often these are more pronounced after the second shot.
Women have reported changes in menstruation after taking mRNA vaccines. Problems with blood clotting (coagulation) — which are also common during COVID-19 disease — are also reported. In the case of the Pfizer COVID mRNA vaccine, these newly revealed documents raise additional questions about both the genotoxicity and reproductive toxicity risks of this product.
Standard studies designed to assess these risks were not performed in compliance with accepted empirical research standards. Furthermore, in key studies designed to test whether the vaccine remains near the injection site or travels throughout the body, Pfizer did not even use the commercial vaccine (BNT162b2) but instead relied on a ‘surrogate’ mRNA producing the luciferase protein.
These new disclosures seem to indicate that the U.S. and other governments are conducting a massive vaccination program with an incompletely characterized experimental vaccine.
It is certainly understandable why the vaccine was rushed into use as an experimental product under emergency use authority, but these new findings suggest that routine quality testing issues were overlooked in the rush to authorize use.
People are now receiving injections with an mRNA gene therapy-based vaccine, which produces the SARS-CoV-2 spike protein in their cells, and the vaccine may be also delivering the mRNA and producing spike protein in unintended organs and tissues (which may include ovaries).”
Toxic Spike Protein Enters Blood Circulation
The assumption that vaccine developers have been working with is that the mRNA in the vaccines (or DNA in the case of Johnson & Johnson and AstraZeneca’s vaccines) would primarily remain in and around the vaccination site, i.e., your deltoid muscle, with a small amount draining into local lymph nodes.
Pfizer’s data, however, show this isn’t the case at all. Using mRNA programmed to produce luciferase protein, as well as mRNA tagged with a radioactive label, Pfizer showed that the majority of the mRNA initially remain near the injection site, but within hours become widely distributed within the body.
We have known for a long time that the spike protein is a pathogenic protein. It is a toxin. It can cause damage in our body if it gets into circulation.
— Dr. Byram Bridle
The mRNA enters your bloodstream and accumulates in a variety of organs, primarily your spleen, bone marrow, liver, adrenal glands and, in women, the ovaries. The spike protein also travel to your heart, brain and lungs, where bleeding and or blood clots can occur as a result, and is expelled in breast milk.
This is a problem, because rather than instructing your muscle cells to produce the spike protein (the antigen that triggers antibody production), spike protein is actually being produced inside your blood vessel walls and various organs, where it can do a great deal of damage.
“It’s the first time ever scientists have been privy to seeing where these messenger RNA [mRNA] vaccines go after vaccination,” Bridle told Pierson.
“Is it a safe assumption that it stays in the shoulder muscle? The short answer is: absolutely not. It’s very disconcerting … We have known for a long time that the spike protein is a pathogenic protein.
It is a toxin. It can cause damage in our body if it gets into circulation … The spike protein on its own is almost entirely responsible for the damage to the cardiovascular system, if it gets into circulation.”
The Spike Protein Is the Problem